CD133 was reported to stain positive 10/11 and 1/11 cases of ACC in one study employing two anti-CD133 antibodies, while data on BMI1, DCLK1, NANOG, and SOX2 expression in ACC were not comprehensive. This evidence concerns the gene DCLK1 and adrenal cortex carcinoma.